Articles Tagged With:
-
Effects of Federal Cuts to STI Programs Could Be Significant
Some sexually transmitted infections (STIs) have risen dramatically since the COVID-19 pandemic. But the hope was that public health clinics’ increased screening and treatment and public awareness campaigns eventually would lead to a decrease in STIs.
-
Immediate Postpartum LARC Is Challenging, Especially in Rural Areas
Rural patients were less likely to have access to immediate postpartum long-acting reversible contraception (LARC) even six years after Pennsylvania Medicaid changed policy to provide a way for providers to receive fair reimbursement for the procedure, new research finds.
-
High School Students Vary in Reporting Contraception Use
A new study using self-reported data from the national Youth Risk Behavior Survey found that overall use of reliable contraceptives by sexually active U.S. female high school students was low.
-
Patients Who Perceive Contraceptive Coercion Report Psychological Distress
When patients perceive contraception coercion from their providers, they are less likely to eventually receive their preferred contraceptive method and also may report higher levels of psychological stress, new research shows.
-
Help Reduce Gender-Related Distress for Patients in Reproductive Healthcare
The challenge for reproductive healthcare providers is meeting the needs of transgender and nonbinary patients in a way that reduces their gender-related distress.
-
Medical Students Need More Training About Benefits of Birth Control Hormones
For medical students — in any discipline — to provide optimal care to women, they need to learn more about contraception, postpartum care, intimate partner violence, and sexual and reproductive health.
-
Telemedicine for Managing Patients with Epilepsy
This retrospective study found telemedicine (TM) visits to be noninferior to in-person (IP) visits for key outpatient epilepsy care outcomes, including medication adjustment, surgery discussions, and avoiding emergency visits. TM was less effective for assessing the neurologic exam, and seizure freedom rates were inconclusive with respect to noninferiority. Although not a full replacement for IP care, TM remains an effective option since its future in healthcare delivery is being reassessed in the wake of the COVID-19 pandemic.
-
Medications for Women Aged 10 to 50 Years with Idiopathic Generalized Epilepsy
After failure of first-line anti-seizure medication, women with idiopathic generalized epilepsy may receive either substitution monotherapy or add-on therapy. There were no significant differences in effectiveness or safety between substitution monotherapy and add-on therapy in this retrospective comparative study.
-
The Effect of High-Dose Vitamin D on Clinically Isolated Syndrome and MS
This study by Thouvenot et al evaluated the effectiveness of high-dose vitamin D treatment on clinically isolated syndrome and early multiple sclerosis as monotherapy and reported a reduced incidence of new disease activity compared to the control group.
-
Can Anti-Amyloid Antibody Treatment Delay the Clinical Onset of Alzheimer’s Disease?
In this open-label extension of the dominantly inherited Alzheimer’s disease gantenerumab trial (DIAN-TU), long-term continuous amyloid clearance over eight or more years in asymptomatic carriers of autosomal dominant Alzheimer’s mutations showed potential to delay symptom onset and slow progression. Shorter duration or partial clearance did not yield measurable clinical benefit, suggesting that only sustained, near-complete amyloid removal may have disease-modifying effects.